Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individual
- PMID: 2848870
- PMCID: PMC442803
- DOI: 10.1172/JCI113841
Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individual
Abstract
Two T helper cell clones recognizing the gp 120 envelope protein of HIV were generated from the peripheral blood of a healthy seropositive individual. These cells were type specific as they proliferated and produced IL 2 when stimulated by an epitope in the amino-terminal half of gp 120 of HIVSF2, but not by a similar region of HIVZr6, a Zairian HIV-1 isolate. These two viruses differ by 26% in the deduced amino sequence of the gp 120 protein. Moreover, the antigenic site(s) recognized by the cloned T cells are distinct from those recognized by envelope-specific antibodies. These observations have important implications for the development and use of anti-HIV vaccines.
Similar articles
-
CD4+ lymphocyte function with early human immunodeficiency virus infection.Proc Natl Acad Sci U S A. 1989 Mar;86(6):1993-7. doi: 10.1073/pnas.86.6.1993. Proc Natl Acad Sci U S A. 1989. PMID: 2564677 Free PMC article.
-
The CD4 antigen: physiological ligand and HIV receptor.Cell. 1988 Mar 11;52(5):631-3. doi: 10.1016/0092-8674(88)90397-2. Cell. 1988. PMID: 2830988 Review. No abstract available.
-
HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.J Infect Dis. 2004 Mar 1;189(5):852-61. doi: 10.1086/380133. Epub 2004 Feb 6. J Infect Dis. 2004. PMID: 14976603
-
Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.AIDS Res Hum Retroviruses. 1987;3(4):409-22. doi: 10.1089/aid.1987.3.409. AIDS Res Hum Retroviruses. 1987. PMID: 2833917
-
HIV infection: the cellular picture.Sci Am. 1988 Oct;259(4):100-9. doi: 10.1038/scientificamerican1088-100. Sci Am. 1988. PMID: 2854299 Review. No abstract available.
Cited by
-
Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies.Clin Exp Immunol. 1994 Sep;97(3):361-6. doi: 10.1111/j.1365-2249.1994.tb06095.x. Clin Exp Immunol. 1994. PMID: 7915974 Free PMC article.
-
Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization.J Virol. 2002 Jul;76(14):6987-99. doi: 10.1128/jvi.76.14.6987-6999.2002. J Virol. 2002. PMID: 12072499 Free PMC article.
-
Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.J Neuroimmune Pharmacol. 2020 Sep;15(3):422-442. doi: 10.1007/s11481-019-09873-y. Epub 2019 Aug 27. J Neuroimmune Pharmacol. 2020. PMID: 31456107 Free PMC article. Review.
-
Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells.Clin Exp Immunol. 1992 Apr;88(1):17-22. doi: 10.1111/j.1365-2249.1992.tb03032.x. Clin Exp Immunol. 1992. PMID: 1563103 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical